II. Definitions
- Chemical Intoxication
- Reversible substance-specific syndrome
- Due to recent ingestion
- Behavioral or psychological maladaption
- Hazardous Use
- Substance use that puts the user at risk for harmful consequences
- Highest risk substances: Heroin, Methamphetamine, crack Cocaine
- Withdrawal
- Substance-specific reaction to cessation of intake
- Substance Misuse
- Substance use that does not meet criteria for Substance Use Disorder AND
- Substance used in hazardous situations, or Alcohol that is used more than low-risk
III. Epidemiology
- Prevalence (2015, U.S. over age 10 years old): 10% (>20 Million)
- Teenagers <14 years old who use substances will have a 33% risk of Substance Use Disorder longterm
- Substance use goes undiagnosed in 43% of cases in the primary care setting
IV. Pathophysiology
V. Preparations: Primary abused substances
- Precautions
- Substances of abuse are difficult to distinguish by sight
- White powder could be Cocaine, Methamphetamine, synthetic Opioids, NBOMe or bath salts
- Crystals could be Crystal Meth, U-47700
- Many substances of abuse are reformulated into tablets
- Fentanyl may be formed in tablets similar to Oxycodone or Hydrocodone
-
Alcohol
- See Alcohol Abuse
-
Ethanol-based hand sanitizer (especially in health care centers)
- Hand sanitizer can cause significant Alcohol Intoxication (60% Alcohol)
- Some abusers of hand sanitizer extract the Alcohol with salt
-
Cannabinoids (Marijuana, K2, Spice)
- See Marijuana (includes Synthetic Cannabinoids such as K2)
- Most common drug of abuse in U.S. and progressively increasing annually among grades 8-12
- Opioids (e.g. Oxycodone, Morphine, Heroin)
- Sedative-Hypnotics
- Stimulants
-
Volatile Inhalants (Sniffing, Huffing, Bagging)
- More common drug of abuse in ages 10-14 years old
- Risk of Sudden Sniffing Death Syndrome
-
Hallucinogens
- Ketamine Abuse (and Methoxetamine)
- Phencyclidine (PCP)
- Other intoxicants
VI. Preparations: Prescription and OTC Drug Abuse
- Amphetamines
- Benzodiazepines
- Opioids
- Dextromethorphan (used at high doses as an Opioid)
-
Diphenhydramine
- Used at high doses as a Hallucinogenic
- Other Anticholinergic Medications have been similarly abused (e.g. Dicyclomine, Oxybutynin)
- Diphenhydramine Overdose also risks Seizures, coma and death
VII. Preparations: Prescribed and OTC Medications that potentiate Drugs of Abuse
-
Albuterol
- Used to enhance effects of crack Cocaine
- Clonidine (Catapres)
-
Bupropion (Wellbutrin)
- Crushed and snorted to induce a high ("poor man's Cocaine")
-
Pseudoephedrine
- Used to synthesize Methamphetamine
- Quetipine (Seroquel)
- Used to enhance the effects of Heroin or for calming
-
Loperamide (Imodium)
- Used in doses as high as 60 mg/day for Opioid effects or for Opioid Withdrawal symptoms
- Gabapentin (Neurontin) or Pregabalin (Lyrica)
- References
- (2015) Presc Lett 22(10):59
VIII. Evaluation
IX. Diagnosis: Substance Use Disorder (DSM-5)
- Problematic pattern of use of intoxicating substance over a 12 month period and
- Not specifically otherwise classified (e.g. Alcohol, Caffeine, Cannabis, Hallucinogen, inhalant, opiod, Sedative, stimulant)
- Clinically Significant Impairment or distress and
- At least 2 of the following criteria present
- Consumption in larger amounts (or for longer duration) than intended
- Persistent desire or unsuccessful attempts to cut down or control substance use
- Significant time spent to obtain the substance (e.g. driving long distances between multiple prescribing doctors)
- Craving or a strong desire or urge to use the substance
- Gives up important social, occupational or recreational activities to recurrently use the substance
- Persistent use despite negative consequences (social, occupational, psychological, physical)
- Recurrent substance us in physically hazardous situations (e.g. DUI)
- Continued substance use despite causing or worsening physical or psychological problems
- Tolerance
- Markedly increased substance amounts needed for Intoxication or
- Markedly diminished effect with the same substance amount
- Withdrawal
- Characteristic withdrawal syndrome for the substance
- Substance is used to avoid withdrawal symptoms
- Qualifiers
- Early Remission
- No substance use criteria (other than craving) are met for 3-12 month period
- Sustained Remission
- No substance use criteria (other than craving) are met for >12 month period
- Controlled Environment
- Patient remains in a setting for which substance access is restricted
- Early Remission
X. Management
- See Chemical Dependency Management
- See Chemical Dependency Brief Counseling
- See Substance Abuse Aftercare
- See Teen Substance Abuse
- See Substance Abuse in Pregnancy
- See Chemical Dependency Resources
- See Alcoholism Management
- See Tobacco Cessation
- See Opioid Addiction Management
- See Methamphetamine Abuse
- See Benzodiazepine Abuse
- See Cannabis Abuse
XI. Resources
XII. References
- (2013) DSM 5 Manual, APA, Washington, D.C.
- (2020) Presc Lett 27(11): 61-2